Halloween Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

NYSE:BMY

Bristol Myers Squibb (BMY)

59.01
-0.57 (0.96%)
as of Oct 9, 2026, 7:10:48 pm Market Open.
162 watching
0
DON'T BUY
Doesn't expect much growth, plus there are some issues.
DON'T BUY
New drug failed and generic drug companies getting into their products. Market share will probably shrink.
TOP PICK
Decent upside potential. Close to a decent technical support. Relatively cheap.
PAST TOP PICK
(Was a top pick on Apr 4 down 11%) Still likes.
DON'T BUY
Very reasonable valuation. Patents are coming off. Prefers Pfizer.
TOP PICK
Has had some negative occurances. At a good price.
BUY
18 X next years earnings makes it very attractive.
TOP PICK
(Was a top pick on Dec 17 up 15%) At a historic low.
DON'T BUY
Broke through a technical base. Generics are giving some tough competition.
TOP PICK
Restructured. In a temporary downturn.
BUY
Good upside potential.
DON'T BUY
Not a fan at this time. Patent expiries coming up. Prefers Pfizer.
Showing 211 to 222 of 222 entries